Product Information
FOCALIN XR 40 MG CAPSULE is a brand product labeled by Novartis Pharmaceuticals Corporation, priced at $5.4141 per EA under NDC 00078043405. Its NADAC has been published 640 times since Nov 28, 2013.
FDA first approved this application on May 26, 2005. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the dexmethylphenidate hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
40 mg/1
Manufacturer
Novartis Pharmaceuticals CorporationNDC
00078043405
Classification
Brand
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
11/19/2025
Active Ingredients
DEXMETHYLPHENIDATE HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA021802FDA Approved
5/26/2005
TE Code
AB
On Market Since
5/31/2005
Pharmacological Classes
Price Statistics
The NADAC for FOCALIN XR 40 MG CAPSULE has been published 640 times since Nov 28, 2013, and over the history we have for it it has declined 26.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $5.4141 per EA |
|---|---|
| All-time high | $14.9553 (Mar 27, 2024) |
| All-time low | $5.3945 (May 21, 2025) |
| 52-week high | $5.4141 |
| 52-week low | $5.4126 |
| Median price | $13.1648 |
| Average price | $11.3958 |
| Largest weekly change | -63.8% (Apr 3, 2024) |
| Weeks tracked | 640 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
+0.0%
3Y
-63.8%
5Y
-61.2%
All
-26.3%
Last surveyed Feb 25, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 69% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Novartis Pharmaceuticals Corporation manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
dexmethylphenidate hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Central Nervous System Stimulant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FOCALIN XR 40 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for FOCALIN XR 40 MG CAPSULE, manufactured by Novartis Pharmaceuticals Corporation, is $5.4141 per EA (NDC 00078043405), effective Feb 25, 2026.
How has the price of FOCALIN XR 40 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for FOCALIN XR 40 MG CAPSULE has declined 26.3%. It has been tracked across 640 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for FOCALIN XR 40 MG CAPSULE?
Since Nov 28, 2013, the NADAC for FOCALIN XR 40 MG CAPSULE has ranged from a low of $5.3945 (May 21, 2025) to a high of $14.9553 (Mar 27, 2024), with a median of $13.1648 per EA.
Are there cheaper alternatives to FOCALIN XR 40 MG CAPSULE?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DEXMETHYLPHENIDATE ER 40 MG CP, is $1.6567 per EA — about 69% below FOCALIN XR 40 MG CAPSULE.
Who manufactures FOCALIN XR 40 MG CAPSULE?
FOCALIN XR 40 MG CAPSULE (NDC 00078043405) is labeled by Novartis Pharmaceuticals Corporation, and CMS classifies it as a brand product.